Assignee
COUR PHARMACEUTICALS DEV COMPANY INC
US·4 granted patents·12 pending applications·5 citations·filing 2016–2023
Top patents by PatentIndex Score
16 records- 0186US11510996B2Covalent polymer-antigen conjugated particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2016·Granted Nov 29, 2022·3 cites·18 claims
- 0276US9919005B2Immune-modifying nanoparticles for the treatment of inflammatory diseasesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2016·Granted Mar 20, 2018·1 cites·17 claims
- 0374US11484506B2Process for the preparation of tolerizing immune-modulating particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2017·Granted Nov 1, 2022·1 cites·27 claims
- 0473US12502436B2Covalent polymer-antigen conjugated particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Granted Dec 23, 2025·0 cites·20 claims
- 0572US2024122864A1Particles encapsulating fusion proteins containing linked epitopesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2023·Application pending·0 cites
- 0670US2020276228A1Immune-modifying nanoparticles for the treatment of inflammatory diseasesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2020·Application pending·0 cites
- 0770US2020276227A1Immune-modifying nanoparticles for the treatment of inflammatory diseasesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2020·Application pending·0 cites
- 0862US2020338116A1Modified immune-modulating particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2020·Application pending·0 cites
- 0962US2020030369A1Modified Immune-Modulating ParticlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2019·Application pending·0 cites
- 1057US2025367274A1Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and ProteinsCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2023·Application pending·0 cites
- 1152US2025319155A1Preparation of tolerizing nanoparticles for the treatment of peanut allergyCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 1251US2024197866A1Treatment of peanut allergy with tolerizing nanoparticlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 1351US2024408186A1Treatment of primary biliary cholangitis (pbc) with tolerizing nanoparticlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 1450US2024201187A1Method of Tracking Maintenance of Immunological ToleranceCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 1545US2019365656A1Particles encapsulating fusion proteins containing linked epitopesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2017·Application pending·0 cites
- 1644US2021030892A1Treatment of celiac disease with tolerizing particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when COUR PHARMACEUTICALS DEV COMPANY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →